| 摘要: |
| 目的：观察益肾止晕颗粒联合甲磺酸倍他司汀治疗良性阵发性位置性眩晕（BPPV）复位后伴残余头晕肾虚血瘀证的临床疗效。方法：将60 例BPPV复位后伴残余头晕肾虚血瘀证患者随机分为治疗组和对照组，每组各30 例。对照组予以甲磺酸倍他司汀治疗，治疗组在对照组治疗的基础上加用益肾止晕颗粒治疗。2组均治疗14 d。治疗结束后比较2组中医证候疗效、中医证候积分、眩晕残障量表（DHI）评分及眩晕视觉模拟评分（VAS）。结果：中医证候疗效总有效率治疗组为86.7%(26/30)，对照组为73.3%(22/30)，组间比较，差异有统计学意义(P<0.05)；2组中医证候积分、DHI中的躯体P评分与总分、VAS评分治疗后均下降，且治疗前后组内比较及治疗后组间比较，差异均有统计学意义（P<0.05）。结论：益肾止晕颗粒联合甲磺酸倍他司汀可有效缓解BPPV复位后伴残余头晕肾虚血瘀证患者的临床症状，减轻其头晕程度，疗效优于单纯使用甲磺酸倍他司汀，值得临床推广应用。 |
| 关键词: 良性阵发性位置性眩晕 残余头晕 肾虚血瘀证 益肾止晕颗粒 甲磺酸倍他司汀 |
| DOI： |
|
|
| Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of residual dizziness after reduction of benign paroxysmal positional vertigo：An analysis of 30 cases |
| JIANG Lingli,LONG Huajun,BAI Zhengping |
| (Hunan University of Chinese Medicine，Changsha 410208，Hunan，China;The Affiliated Hospital of Hunan Academy of Chinese Medicine，Changsha 410006，Hunan，China) |
| Abstract: |
| Objective：To investigate the clinical effect of Yishen Zhiyun granules combined with betahistine mesylate in the treatment of residual dizziness with the syndrome of kidney deficiency and blood stasis after reduction of benign paroxysmal positional vertigo (BPPV).Methods：A total of 60 patients with residual dizziness and the syndrome of kidney deficiency and blood stasis after BPPV reduction were randomly divided into treatment group and control group，with 30 patients in each group.The patients in the control group were given betahistine mesylate，and those in the treatment group were given Yishen Zhiyun granules in addition to the treatment in the control group.The course of treatment was 14 days for both groups，and after treatment，the two groups were compared in terms of the treatment outcome of TCM syndrome，TCM syndrome score，Dizziness Handicap Inventory (DHI) score，and Visual Analogue Scale (VAS) score of dizziness.Results：There was a significant difference in the overall response rate of TCM syndrome between the treatment group and the control group ［86.7%(26/30)vs 73.3%(22/30)，P<0.05］.Both groups had significant reductions in TCM syndrome score，DIH-P score and total score of DHI，and VAS score after treatment，and there were significant differences in these scores between the two groups after treatment (P＜0.05).Conclusion：In the treatment of patients with residual dizziness and the syndrome of kidney deficiency and blood stasis after BPPV reduction，Yishen Zhiyun granules combined withbetahistine mesylate can effectively improve clinical symptoms and alleviate the degree of dizziness，with a better clinical effect than betahistine mesylate alone.Therefore，it holds promise for clinical application. |
| Key words: benign paroxysmal positional vertigo residual dizziness syndrome of kidney deficiency and blood stasis Yishen Zhiyun granules betahistine mesylate |
